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http://dReply to “Novel avian-origin influenza A (H7N9) virus in
the human”We thank Dr. Viroj for his careful reading of our article and
his description of some important considerations of the novel
avian-original influenza A (H7N9) virus in the human.
As Viroj1 mentioned, this virus (H7N9) has several human
virus-like signatures, and possible pandemic would most
likely be due to the wide spreading of the pathogenic virus
from infected avian. In our overview of the emergence of a
new form of avian-origin influenza A virus-H7N9 e causing
first time human infection, we noted that there has been
speculation as to whether this virus will be the agent of the
next influenza pandemic.2 Liu et al.3 reported that this novel
avian influenza A H7N9 virus originated from multiple reas-
sortment events. They hypothesized that human infection with
H7N9 viruses resulted from a reassortment of avian influenza
viruses of at least four origins- duck origin for HA, duck
(probably also wild bird) origin for NA, and at least two H9N2
chicken viruses for the internal genes. Mutations in H7N9
strains that could favor high-affinity interaction with human
receptors in the upper respiratory tract are a prerequisite for
virus transmission by the aerosol route. As the H7N9 virus
does not cause disease in poultry, a decline in the number of
new human cases was noted when there was closure of poultry
markets and culling of birds in China. But the timing and
probability that this H7N9 will acquire the capacity for
human-to-human transmission is impossible to estimate. Chen
et al.4 reported that, so far, out of the four confirmed clusters
of two or more cases that were in close contact, the patients
did not appear to have known exposure to each other. Hu Y
et al.5 also reported the emergence of the oseltamivir-resistant
virus with the Arg292Lys mutation in two patients among 14
adults infected with H7N9 viruses. Due to the fact that the
process of resistance emergence is associated with variant
virus fitness, the fitness and stability of the Arg292Lys901/$ - see front matter Copyright  2013 Elsevier Taiwan LLC and the C
x.doi.org/10.1016/j.jcma.2013.07.013mutation in avian influenza A (H7N9) needs to be inves-
tigated. The appearance of antiviral resistance emerging in
avain influenza A (H7N9) viruses is concerning, and should be
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